Inogen develops portable oxygen concentrators and oxygen therapy solutions for patients requiring supplemental oxygen. Self-described as a provider focused on mobility for oxygen therapy.

Inogen

Inogen Connect Portable Oxygen

Domain Not Resolving

SSL by Default

Amazon

nginx

DNSSEC

jsDelivr

Amazon Virginia Region

DigiCert SSL

Microsoft Azure

Oracle Cloud

Founder

Ali Bauerlein

Med Tech Business Founder, Leader & Strategist | Innovator & Capability Builder

Byron Myers

Co-Owner and VP Operations

Chuck Kenlein

CEO & Founder

Ivel De Freitas

EVP, General Counsel, Corporate Secretary and Chief Compliance Officer

Jason Somer

Owner

Karen Laurie

EVP, Chief Technology Officer

Mr. Stanislav Glezer

Member of the Board of Advisors

Natalie DeMarco

Stanislav Glezer

Founder and CEO

Steven Frye

Heath Lukatch

Steve Cooper

Kevin Smith

Benjamin Anderson-Ray

Walter Tendler

Loren Mcfarland

Heather Rider

Brenton Taylor

Eric Pauls

VP of Sales, North America

General Counsel & Executive Vice President, Business Development

Dr. Stanislav Glezer

George Parr

EVP & Chief Commercial Officer

Chief Executive Officer and President

Julie Bobbitt

Senior Manager Sales Operations

Matt Pigeon

Senior Vice President Finance and Business Development

Michael Bourque

Chief Financial Officer

Health Care Public Companies With More Than 10 Employees

Western US Public Companies With More Than $100M in Revenue

West Coast Public Companies With More Than $1M in Revenue

United States Public Companies With Less Than $1B in Revenue

Inogen is innovation in oxygen therapy. Our mission is to improve freedom and independence for oxygen therapy patients through innovative products and services.  As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes.

Novo Holdings

Venture Round - Inogen

Series E - Inogen

Versant Ventures

Arboretum Ventures

Series D - Inogen

Series B - Inogen

Goleta

California

United States

North America

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Inogen Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Kevin Smith to Lead Business Development Efforts at Inogen

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Inogen names Kevin Smith as new General Counsel

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased ...

Inogen publishes study linking portable oxygen concentrators, higher survival

Global Medical Oxygen Cylinders Market to Accelerate Substantially by 2030, Estimates DelveInsight | Key Companies ...

Inogen executive sells $85.6k worth of shares By Investing.com

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen, Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Oct 30, 2024 7:25 AM	bc3f2fa8
public peers	general	Oct 29, 2024 12:31 PM	bb21c0ed
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Oct 30, 2024 6:01 AM	e0a88dc5
company summary	general
signals	general	Oct 29, 2024 12:31 PM	7f37f39a
crunchbase trigger	general	Oct 29, 2024 12:31 PM	882e70b1
crunchbase profile	general	Oct 29, 2024 2:18 PM	45b3aa52
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	a3e363e5
peers	general	Oct 29, 2024 12:31 PM	60628b2a
news basic	general	Oct 29, 2024 12:31 PM	a10f2a4a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:INOGEN

Inogen

Last Close

9.21

22/11 21:00

Market Cap

199.70M

Beta: -

Volume Today

407.81K

Avg: -